Shares of AbbVie rose 2.95% to $113.02 at 15:03 EST on Wednesday, after four consecutive sessions in a row of gains. NYSE Composite is rising 0.04% to $15,016.44, following last session’s upward trend, This seems, up until now, a somewhat positive trend trading session today.
AbbVie’s last close was $109.78, 0.04% below its 52-week high of $113.07.
AbbVie’s sales growth is 57.7% for the current quarter and 50.4% for the next. The company’s growth estimates for the current quarter and the next is 29.4% and 18.2%, respectively.
Year-on-year quarterly revenue growth grew by 52.2%, now sitting on 40.65B for the twelve trailing months.
AbbVie’s last day, last week, and last month’s average volatility was 0.70%, 0.61%, and 0.10%, respectively.
AbbVie’s last day, last week, and last month’s high and low average amplitude percentage was 1.52%, 1.96%, and 2.01%, respectively.
AbbVie’s Stock Yearly Top and Bottom Value
AbbVie’s stock is valued at $113.02 at 15:03 EST, under its 52-week high of $113.07 and way higher than its 52-week low of $62.55.
AbbVie’s Moving Average
AbbVie’s worth is higher than its 50-day moving average of $105.44 and way above its 200-day moving average of $95.77.